EWING, N.J.--(BUSINESS WIRE)--Celator Pharmaceuticals, Inc., (OTCBB:CLPM), a pharmaceutical company developing new and more effective therapies to treat cancer, today announced that its common stock has been approved for quotation on the OTC Bulletin Board (OTCBB) and the OTC Market Group’s OTC Link quotation system under the ticker symbol “CLPM.” The company expects that trading will commence today.
Help employers find you! Check out all the jobs and post your resume.
